Compare ARK Genomic Revolution ETF (ARKG) vs KraneShares Electric Vehicles and Future Mobility (KARS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs KraneShares Electric Vehicles and Future Mobility — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while KraneShares Electric Vehicles and Future Mobility trades at $30.54. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.
| ARKG | KARS | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $38.01 |
52-Week Low | $23.09 | $22.89 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
KARS trades at $30.575, up 0.21% today, but technical indicators are bearish with moving averages and oscillators signaling sell pressure. Support levels are clustered around $30, with resistance at $31. Recent news highlights global EV sales growth, particularly in Europe and China, though U.S. adoption lags. Financial ratios are unavailable, limiting fundamental clarity.
The outlook is cautious due to bearish technicals and competitive risks from Chinese EV makers. Upside depends on broader EV adoption and regulatory developments, but tariffs and market volatility pose headwinds. Investors should await earnings data for fundamental validation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About KraneShares Electric Vehicles and Future Mobility
KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →
